-
2022-502227-22-00
4
2023-10-25
Autoimmune disease
-
2023-503627-26-00
4
2023-09-28
Metastatic breast cancer
-
2023-503659-88-00
5
2023-09-05
Obesity
-
2022-503071-28-00
5
2023-08-31
Squamous Non-small cell Lung Cancer
-
2023-508267-69-00
3
2023-08-11
Subjects with Aadvanced solid tumors for whom life-prolonging therapie
-
2022-500449-26-00
6
2023-08-03
Type 2 diabetes mellitus (T2DM)
-
2023-509704-14-00
4
2023-04-28
Non-cirrhotic non-alcoholic steatohepatitis with fibrosis
-
2023-510470-13-00
4
2023-03-10
Overweight and Obesity
-
2023-508860-31-00
5
2023-02-28
Stage IV colon or rectal adenocarcinoma (mCRC).
-
2024-514060-10-00
4
2023-02-02
Advanced triple-negative breast cancer (TNBC), Advanced HR[+]/HER2[–]
-
2023-503793-20-00
5
2023-01-18
Prevention of ischemic stroke in patients post acute non-cardioembolic
-
2022-500594-13-00
4
2022-12-14
"Non-Alcoholic Steatohepatatis (NASH) is the progressive form of Non-A
-
2023-503529-20-00
4
2022-10-17
BRCA Mutations and Early Stage HER2-Negative Breast Cancer
-
2024-510729-24-00
6
2022-09-01
Chronic Migrane, Migrane, Medication Overuse Headache
-
2023-509095-42-00
4
2022-07-14
Colorectal cancer
-
2024-514372-40-00
5
2022-04-12
Anterior ST-Elevation Myocardial Infarction
-
2023-508828-35-01
5
2022-03-28
Patients with advanced hormone receptor-positive/HER2- negative/HER2-E
-
2024-512052-38-00
9
2021-12-02
Advanced triple negative breast cancer
-
2024-513940-27-00
4
2021-11-19
Chronic low back pain
-
2024-519633-35-00
6
2021-10-25
Resectable pancreatic adenocarcinoma with risk factors
-
2023-510183-12-00
5
2021-07-05
Chronic migraine
-
2024-515167-56-00
11
2021-06-22
HIV
-
2023-507977-16-00
4
2021-05-10
Lupus Nephritis (LN)
Immunoglobulin A Nephropathy (IgAN)
-
2023-509591-42-00
4
2021-05-04
HR-positive/HER2-negative breast cancer